R. Li

Oxygen AIIC, Chan Long, Chao Liu et al.

JD.com, one of the world's largest e-commerce platforms, serves over 700 million active users and millions of merchants, with a catalog of tens of billions of SKUs. At this scale, high-quality, structured item knowledge underpins a better consumer experience, lower management costs, and higher operational efficiency-yet producing and serving it poses three industrial-scale challenges: fast-emerging concepts, high-quality knowledge production for massive SKUs, and diverse downstream requirements. To address these challenges, we present the JD Oxygen AI Item Center (Oxygen AIIC), an industrial-scale platform built on LLMs/VLMs for item-knowledge production and service. Oxygen AIIC is built around four core pillars: (i) ontology engineering driven by efficient human-AI collaboration, which supports the dynamic evolution and agile expansion of an ontology with millions of entries; (ii) a "Semantic Search then Discrimination"(S2D) knowledge identification architecture that, combined with throughput improvement strategies, enables scalable, extensible, and high-throughput AI Item Library production for tens of billions of SKUs; (iii) self-evolving item-understanding LLMs/VLMs that improve in a stable and controllable manner, enabling knowledge production with 94.2% precision and 82.8% recall; and (iv) a unified item tunnel that serves as the data and service hub. Oxygen AIIC now covers tens of thousands of JD categories and processes hundreds of millions of item updates per day on Huawei Ascend NPUs. It has accumulated hundreds of billions of item-knowledge assets. Deployed across core business scenarios-including search, recommendation, operations, category planning-Oxygen AIIC has delivered measurable gains at scale. Search-traffic coverage reaches 80.4%, item-information quality issues drop by 37%, the automated fill rate of core attributes during item listing exceeds 80%.

R. Li, J. Liu, X. L. Deng et al.

The diagnosis and monitoring of Castrate Resistant Prostate Cancer (CRPC) are crucial for cancer patients, but the current models (such as P-NET) have limitations in terms of parameter count, generalization, and cost. To address the issue, we develop a more accurate and efficient Prostate Cancer patient condition prediction model, named PR-NET. By compressing and optimizing the network structure of P-NET, the model complexity is reduced while maintaining high accuracy and interpretability. The PR-NET demonstrated superior performance in predicting prostate cancer patient outcomes, outshining P-NET and six other traditional models with a significant margin. In our rigorous evaluation, PR-NET not only achieved impressive average AUC and Recall scores of 0.94 and 0.83, respectively, on known data but also maintained robust generalizability on five unknown datasets with a higher average AUC of 0.73 and Recall of 0.72, compared to P-NET's 0.68 and 0.5. PR-NET's efficiency was evidenced by its shorter average training and inference times, and its gene-level analysis revealed 46 key genes, demonstrating its enhanced predictive power and efficiency in identifying critical biomarkers for prostate cancer. Future research can further expand its application domains and optimize the model's performance and reliability.